201019028U : UMR_S951 Integrated genetic approaches in therapeutic discovery for rare diseases
- Unité de recherche
Responsables
Directrice - Anne GALY à partir du 01/01/2010galy@genethon.fr
Directrice adjointe - Ana BUJ-BELLO à partir du 01/01/2022
abujbello@genethon.fr
Adresse : GENETHON - 1 BIS RUE DE L'INTERNATIONALE 91002 EVRY
Site : www.genethon.fr
Descriptif :
INTEGRARE (Integrated genetic approaches in therapeutic discovery for rare diseases, UMR_S951) is a mixed research unit specialized in translational research for the gene therapy of rare genetic disorders. This UMR is located at Généthon, a laboratory of AFM/Téléthon, in partnership with Inserm, the University of Evry - Université Paris Saclay. This partnership offers unique possibilities to translate research discoveries into treatments with possible support in process development, pharmaceutical competencies and a preclinical environment to transform research projects into clinical candidates and innovations. Each of the research laboratories of the UMR is recognized as functional unit directed by group leaders who manage the activity of scientists, technicians, fellows and students on one or more therapeutic or research projects.
Ecole(s) doctorale(s) de rattachement :
- ED 569 - INNOVATION THÉRAPEUTIQUE: DU FONDAMENTAL À L'APPLIQUÉ
- ED 577 - STRUCTURE ET DYNAMIQUE DES SYSTÈMES VIVANTS
Rattachée au(x) thème(s) de recherche suivant(s):
- Understanding the physiopathology of diseases of interest with animal or cellular models integrating genetics and vectorology aspects to help design and probe various gene therapies and predict thei
- Technological expertise including conception of new gene delivery tools and omics analyses,
- Understanding the physiopathology of diseases of interest with animal or cellular models integrating genetics and vectorology aspects to help design and probe various gene therapies and predict thei
- Obtaining new proof of concepts for candidate gene therapies and combined approaches with thorough preclinical evaluations including new functional tests, to treat monogenic diseases such as congeni
Liens avec d'autres structures :
Aucun
Aucun
Contact: galy@genethon.fr
Année de création : 2010
Site ESR :
Aucun
Classement scientifique ERC :
- LS7 : Prevention, Diagnosis and Treatment of Human Diseases : Medical technologies and tools for prevention, diagnosis and treatment of human diseases, therapeutic approaches and interventions, pharmacology, preventative medicine, epidemiology and public health, digital medicine
Domaine scientifique :
- 5 : Biologie, médecine et santé 2010
|
INSERM
-
Institut national de la sante et de la recherche medicale
(U 951)
(établissement tutelle à partir de 2005) |
|
|
EVRY
-
Université d'Evry-Val d'Essonne
(U 951)
(établissement tutelle à partir de 2010) |
Etablissement référent |
|
U PARIS-SACLAY
-
Université Paris-Saclay
(établissement participant à partir de 2020) |
-
Libellé(s) de structure
- 15/03/2017 : Integrated genetic approaches in therapeutic discovery for rare
- 10/06/2010 : UMR_S951
- 10/06/2010 : IMMUNOLOGIE MOLECULAIRE ET BIOTHERAPIES INNOVANTES
-
Label et Numéro d'établissement
-
13/05/2020 : U 951
U PARIS-SACLAY - Université Paris-Saclay -
09/04/2018 : U 951
INSERM - Institut national de la sante et de la recherche medicale (U 951) -
10/06/2010 : U 951
EVRY - Université d'Evry-Val d'Essonne (U 951)
-
13/05/2020 : U 951
-
Etablissements
- 2010 - 2019 : EPHE PARIS- Ecole Pratique des Hautes Etudes Paris